Table 1.
Characteristics | Mean± SD/N (%) |
---|---|
Age, years | 52.25±10.45 |
BMI, kg/m2 | 24.22±4.11 |
Year of education | 10.77±3.95 |
Marital status, married | 115 (79.3) |
Employment | 75 (51.7) |
Menopause Status (Menopause) | 106 (73.1) |
Comorbidity | |
Psychiatric history | 27 (18.6) |
Diabetes | 10 (6.9) |
Hypertension | 29 (20.0) |
Cancer stage⋆ | |
0 | 25 (17.4) |
1 | 44 (30.6) |
2 | 57 (39.6) |
3 | 18 (12.4) |
Systemic treatments | |
Chemotherapy | 38 (26.2) |
Radiotherapy | 46 (31.7) |
Hormone therapy | 61 (42.1) |
Family History | |
Breast Cancer | 30 (20.7) |
Psychiatric disorders | 13 (9.0) |
Surgical procedure⋆ | |
Partial mastectomy | 114 (79.2) |
Total mastectomy | 30 (20.8) |
Cancer subtypes | |
ER, positive | 114 (78.6) |
PR, positive | 97 (66.9) |
Her2_neu, negative | 90 (62.1) |
Her2_neu, positive | 25 (17.2) |
Her2_neu, equivocal | 28 (19.3) |
Lymph node involvement | 43 (29.7) |
Self-report inventory | |
Family support (family APGAR score) | 6.26±3.16 |
Depression (PHQ-9) | 4.79±4.47 |
EQ-VAS | 71.91±19.00 |
FACT-Cog, total score | 115.94±14.26 |
PTSD (SPAN-C) | 0.77±2.01 |
PTGI (n=108), total scores | 32.54±26.17 |
Chronic pain (score) | 1.37±2.24 |
Fatigue (BFI, n=108) | |
Fatigue severity | 4.71±6.42 |
Fatigue interference | 3.31±5.63 |
Alexithymia (TAS, n=108) | 55.31±5.90 |
Anxiety symptoms (HADS) (n=108) | 3.85±3.78 |
Note: ⋆There was one missing piece of data on cancer stage and surgical procedure.
Abbreviations: BFI, Brief Fatigue Inventory; ER, estrogen receptor; HADS-A, Hospital Anxiety and Depression Scale-Anxiety symptoms; Her2, human epidermal growth factor receptor; PHQ-9, Patient Health Questionnaire-9; PR, progesterone receptor; PTGI, Post-traumatic Growth Inventory; TAS, Toronto Alexithymia Scale; VAS, visual analog scale.